120 related articles for article (PubMed ID: 7650534)
21. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
23. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
Valladares-Neto DC; Buchsbaum MS; Evans WJ; Nguyen D; Nguyen P; Siegel BV; Stanley J; Starr A; Guich S; Rice D
Neuropsychobiology; 1995; 31(4):173-81. PubMed ID: 7659198
[TBL] [Abstract][Full Text] [Related]
24. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
25. High-resolution PET studies in Alzheimer's disease.
Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
[TBL] [Abstract][Full Text] [Related]
26. Auditory and visual event-related potentials and flash visual evoked potentials in Alzheimer's disease: correlations with Mini-Mental State Examination and Raven's Coloured Progressive Matrices.
Tanaka F; Kachi T; Yamada T; Sobue G
J Neurol Sci; 1998; 156(1):83-8. PubMed ID: 9559992
[TBL] [Abstract][Full Text] [Related]
27. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
[TBL] [Abstract][Full Text] [Related]
28. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Koss E; Friedland RP; Ober BA; Jagust WJ
Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
[TBL] [Abstract][Full Text] [Related]
29. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
32. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
33. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Minoshima S; Giordani B; Berent S; Frey KA; Foster NL; Kuhl DE
Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
[TBL] [Abstract][Full Text] [Related]
34. Comparability of FDG PET studies in probable Alzheimer's disease.
Herholz K; Perani D; Salmon E; Franck G; Fazio F; Heiss WD; Comar D
J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064
[TBL] [Abstract][Full Text] [Related]
35. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
36. Cerebral glucose metabolism in patients with frontotemporal dementia.
Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
[TBL] [Abstract][Full Text] [Related]
37. 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
McGeer EG; Peppard RP; McGeer PL; Tuokko H; Crockett D; Parks R; Akiyama H; Calne DB; Beattie BL; Harrop R
Can J Neurol Sci; 1990 Feb; 17(1):1-11. PubMed ID: 2311010
[TBL] [Abstract][Full Text] [Related]
38. NIH Conference. Brain imaging: aging and dementia.
Cutler NR; Duara R; Creasey H; Grady CL; Haxby JV; Schapiro MB; Rapoport SI
Ann Intern Med; 1984 Sep; 101(3):355-69. PubMed ID: 6235763
[TBL] [Abstract][Full Text] [Related]
39. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
[TBL] [Abstract][Full Text] [Related]
40. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
Bokde AL; Teipel SJ; Drzezga A; Thissen J; Bartenstein P; Dong W; Leinsinger G; Born C; Schwaiger M; Moeller HJ; Hampel H
Dement Geriatr Cogn Disord; 2005; 20(6):352-7. PubMed ID: 16192725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
